HealthInvest Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Buy |
24,328
+1,520
| +7% | +$677K | 4.64% | 7 |
|
|
2025
Q1 | $11.1M | Buy |
22,808
+551
| +2% | +$267K | 4.88% | 7 |
|
|
2024
Q4 | $7.6M | Buy |
22,257
+5,264
| +31% | +$1.8M | 3.6% | 10 |
|
|
2024
Q3 | $7.9M | Buy |
16,993
+1,898
| +13% | +$883K | 3.71% | 10 |
|
|
2024
Q2 | $7.08M | Buy |
15,095
+3,800
| +34% | +$1.78M | 4.31% | 8 |
|
|
2024
Q1 | $4.72M | Buy |
11,295
+2,165
| +24% | +$905K | 2.87% | 14 |
|
|
2023
Q4 | $3.71M | Buy |
+9,130
| New | +$3.71M | 2.91% | 17 |
|
|
2022
Q4 | $62.4K | Buy |
+216
| New | +$62.4K | 0.12% | 18 |
|
|
2021
Q3 | – | Sell |
-52,000
| Closed | -$10.5M | – | 19 |
|
|
2021
Q2 | $10.5M | Buy |
52,000
+17,000
| +49% | +$3.43M | 9.94% | 3 |
|
|
2021
Q1 | $7.52M | Buy |
+35,000
| New | +$7.52M | 5.99% | 7 |
|